Trending
July 16, 2024 Scorpion Therapeutics Closes $150 Million Series C FinancingJuly 10, 2024 Interview with Kate Dilligan, CEO & Founder of Cooler HeadsApril 23, 2024 Incyte to Acquire Escient PharmaceuticalsMarch 19, 2024 Rapport Therapeutics Appoints John Maraganore to Board of DirectorsMarch 7, 2024 Johnson & Johnson Completes Ambrx Acquisition
Featured
July 16, 2024
Scorpion Therapeutics Closes $150 Million Series C Financing
BOSTON--(BUSINESS WIRE)--Scorpion Therapeutics, Inc., a pioneering clinical-stage oncology company dedicated to... Read more »
July 10, 2024
Interview with Kate Dilligan, CEO & Founder of Cooler Heads
Kate Dilligan founded Cooler Heads from her personal experience trying to cope with the overwhelming side effects of... Read more »
April 23, 2024
Incyte to Acquire Escient Pharmaceuticals
WILMINGTON, Del. & SAN DIEGO--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) and Escient Pharmaceuticals, a clinical-stage... Read more »
October 3, 2024
Resilience Secures Funding to Expand Domestic Manufacturing for Critical Pharmaceutical Ingredients
September 25, 2024
NaNotics Selected for Space-H Accelerator to Explore Astronaut Disease Treatment in Space
September 18, 2024
Riverside Partners to Combine Portfolio Companies, Sequoia Biotech Consulting and Syner-G BioPharma Group
